Document is current
Any future updates will be listed below
-
Authors
Fernández, René https://orcid.org/0000-0002-0426-8536
Soza-Ried, Cristian
Kramer, Vasko
Krieger, Korbinian
Müller, Cristina
Qin, Yun
Fliegert, Frank
Ritt, Philipp
Zhernosekov, Konstantin
Amaral, Horacio
Estay, Roberto
Nicolai, Heinz
- License Information
-
More Information
Article History
Received: 3 July 2025
Accepted: 13 October 2025
First Online: 7 November 2025
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments. The study was approved by the regional ethics committee board (CEC SSM Oriente, permit 20210521).
: Written informed consent for participation and publication was obtained from all individual participants included in the study.
: The authors declare the following competing financial interest(s): Patent applications on PSMA ligands with albumin-binding entities have been filed by ITM Medical Isotopes GmbH, Germany and the Paul Scherrer Institute, Switzerland. KZ and CM are listed as co-inventors. The authors further declare non-financial interest(s): non-carrier-added lutetium-177 was provided by ITM Medical Isotopes GmbH, Germany.
